Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine and Ketorolac Wound Infiltration for Postoperative Pain After Cesarean Delivery
NCT02829944Phase 4Completed
- Sponsor
- Duke University
- Start
- Nov 2016
- Primary completion
- Mar 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of ropivacaine, ketorolac in pain, sponsored by Duke University. Started Nov 2016; status: completed.
02
Drugs
ropivacaineketorolac
03
Conditions
pain
Beyond the preview
Go deeper on NCT02829944.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02829944.